The administration of intravenous gadolinium-containing contrast media was historically considered safe in patients with impaired renal function. This changed in 2006 when the FDA first reported the ...
Abstract: The use of biochemical markers in the kidney healthcare has advanced dramatically in recent years. Creatinine and Blood Urea Nitrogen (BUN) are two of the most essential biochemical markers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results